AHL
PGEN icon

Abel Hall LLC’s Precigen PGEN Stock Holding History

Abel Hall LLC’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64K Buy
11,229
+168
+2% +$726 0.01% 880
2026
Q1 		$42.8K Buy
11,061
+533
+5% +$2.19K 0.01% 755
2025
Q4 		$44K Buy
+10,528
New +$40.7K 0.01% 668

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Abel Hall LLC's PGEN Position: Q2 2026 in Review

Abel Hall LLC increased its Precigen (PGEN) stake by 1.5% in Q2 2026, buying an estimated $726 and bringing the position to 11,229 shares worth $64K. The position accounts for 0.01% of the portfolio, ranked #880.

Abel Hall LLC first reported a position in PGEN in Q4 2025 and has held it in 3 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Abel Hall LLC held 11,229 shares of Precigen worth $64K as of Q2 2026.
  • Abel Hall LLC bought 168 Precigen shares in Q2 2026, an estimated $726.
  • Precigen made up 0.01% of Abel Hall LLC's portfolio in Q2 2026, its #880 holding.
  • Abel Hall LLC first reported a position in Precigen in Q4 2025 and has held it in 3 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.